|1.||Berke, Gideon: 1 article (05/2003)|
|2.||Krutovskikh, Vladimir: 1 article (05/2003)|
|3.||Yamasaki, Hiroshi: 1 article (05/2003)|
05/30/2003 - "Two Cx37 mutations have been implicated: a Cys-54-Gln substitution in FEQNTAQP (MUT 1) and FEQNTAQA (MUT 2); an additional Pro-59-Ala substitution has been proposed in MUT 2. A Cys-54-Gln mutation in both tumors requires three base changes (TGT-to-CAG) to have occurred twice in independently derived tumors. "
|1.||MUT 1 peptide